The Central Drugs Standard Control Organization has launched an investigation into Maiden Pharmaceuticals, based in Delhi after the World Health Organization linked the deaths of nearly 66 children in the Gambia to the company’s cold and cough syrups.
According to WHO Director-General Tedros Adhanom Ghebreyesus, the four syrups “have been potentially linked to acute kidney injuries and 66 deaths among children.”
Also Read: 5G Price In India: How Much Will You Be Paying For It?
The government has launched an investigation into the cough syrups manufactured by Haryana-based firm Maiden Pharmaceutical, which manufactures medicines at its facilities in Sonipat and sells them domestically as well as exporting them to countries in Asia, Africa, and Latin America, a day after the World Health Organization (WHO) warned that four India-made cough syrups could be linked to the deaths of 66 children in The Gambia.
WHO warns against Indian cough syrups after 66 children died in Gambia#WHO #Gambia #CoughSyrup https://t.co/kwdFcoCDeg
— Financial Express (@FinancialXpress) October 6, 2022
According to sources, M/s Maiden Pharmaceutical Limited in Haryana’s Sonepat manufactured cough syrups. According to the information available at this time, the firm appears to have exported these products only to The Gambia. The company has yet to respond to the charges.
The WHO has warned that the syrups may have been distributed outside of the West African country, posing a global risk.
According to WHO Director-General Tedros Adhanom Ghebreyesus, the four cold and cough syrups “have been potentially linked to acute kidney injuries and 66 deaths among children.”
The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup, according to the WHO alert.
According to the WHO, lab analysis revealed unacceptable levels of diethylene glycol and ethylene glycol, both of which are toxic when consumed. The Gambia’s government said last month that it was also looking into the deaths, following a spike in cases of acute kidney injury among children under the age of five in late July.
Several children in the Gambia became ill with kidney problems three to five days after taking a paracetamol syrup sold locally. By August, 28 people had died, but health officials predicted that number would rise. According to WHO, 66 people have died as of Wednesday.
